Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanomaActive, not recruitingPhase 22026-03-16NCT05907954

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
IDEAYA Biosciences12

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alfred HealthMelbourneAustralia32
Charité - Universitätsmedizin BerlinBerlinGermany16
Fondazione IRCCS Istituto Nazionale TumoriMilanItaly10
Fondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly34
HonorHealth Research InstituteScottsdaleUnited States36
Institute CurieParisFrance1
Leiden University Medical CenterLeidenNetherlands22
Mayo Clinic RochesterRochesterUnited States133
Moores Cancer CenterLa JollaUnited States7
NorthwellManhassetUnited States1
Princess Margaret Cancer CentreTorontoCanada11
Sarah Cannon Research InstituteNashvilleUnited States119
St. Vincent's Health SydneySydneyAustralia1
Stanford Cancer InstitutePalo AltoUnited States11
The Cancer and Hematology CentersGrand RapidsUnited States4
Thomas Jefferson UniversityPhiladelphiaUnited States165
University of MiamiMiamiUnited States22
University of Texas Southwestern Medical CenterDallasUnited States249